JTEC Corporation

3446.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 3446.T stands at 11.4B. In comparison, 7741.T has a market cap of 9.2T. Regarding current trading prices, 3446.T is priced at ¥1,944.00, while 7741.T trades at ¥27,510.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

3446.T currently has a P/E ratio of 125.91, whereas 7741.T's P/E ratio is 37.02. In terms of profitability, 3446.T's ROE is +0.03%, compared to 7741.T's ROE of +0.25%. Regarding short-term risk, 3446.T is less volatile compared to 7741.T. This indicates potentially lower risk in terms of short-term price fluctuations for 3446.T.Check 7741.T's competition here

3446.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 3446.T stands at 11.4B. In comparison, 4543.T has a market cap of 2.9T. Regarding current trading prices, 3446.T is priced at ¥1,944.00, while 4543.T trades at ¥1,957.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

3446.T currently has a P/E ratio of 125.91, whereas 4543.T's P/E ratio is 22.11. In terms of profitability, 3446.T's ROE is +0.03%, compared to 4543.T's ROE of +0.09%. Regarding short-term risk, 3446.T is less volatile compared to 4543.T. This indicates potentially lower risk in terms of short-term price fluctuations for 3446.T.Check 4543.T's competition here

3446.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 3446.T stands at 11.4B. In comparison, 7733.T has a market cap of 1.7T. Regarding current trading prices, 3446.T is priced at ¥1,944.00, while 7733.T trades at ¥1,534.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

3446.T currently has a P/E ratio of 125.91, whereas 7733.T's P/E ratio is 17.79. In terms of profitability, 3446.T's ROE is +0.03%, compared to 7733.T's ROE of +0.11%. Regarding short-term risk, 3446.T is less volatile compared to 7733.T. This indicates potentially lower risk in terms of short-term price fluctuations for 3446.T.Check 7733.T's competition here

3446.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 3446.T stands at 11.4B. In comparison, 7747.T has a market cap of 879B. Regarding current trading prices, 3446.T is priced at ¥1,944.00, while 7747.T trades at ¥3,313.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

3446.T currently has a P/E ratio of 125.91, whereas 7747.T's P/E ratio is 50.03. In terms of profitability, 3446.T's ROE is +0.03%, compared to 7747.T's ROE of +0.12%. Regarding short-term risk, 3446.T is less volatile compared to 7747.T. This indicates potentially lower risk in terms of short-term price fluctuations for 3446.T.Check 7747.T's competition here

3446.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 3446.T stands at 11.4B. In comparison, 6869.T has a market cap of 822B. Regarding current trading prices, 3446.T is priced at ¥1,944.00, while 6869.T trades at ¥1,319.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

3446.T currently has a P/E ratio of 125.91, whereas 6869.T's P/E ratio is 17.63. In terms of profitability, 3446.T's ROE is +0.03%, compared to 6869.T's ROE of +0.09%. Regarding short-term risk, 3446.T is less volatile compared to 6869.T. This indicates potentially lower risk in terms of short-term price fluctuations for 3446.T.Check 6869.T's competition here

3446.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 3446.T stands at 11.4B. In comparison, 8086.T has a market cap of 243.6B. Regarding current trading prices, 3446.T is priced at ¥1,944.00, while 8086.T trades at ¥1,493.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

3446.T currently has a P/E ratio of 125.91, whereas 8086.T's P/E ratio is 25.24. In terms of profitability, 3446.T's ROE is +0.03%, compared to 8086.T's ROE of +0.06%. Regarding short-term risk, 3446.T is more volatile compared to 8086.T. This indicates potentially higher risk in terms of short-term price fluctuations for 3446.T.Check 8086.T's competition here

3446.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 3446.T stands at 11.4B. In comparison, 7716.T has a market cap of 232.4B. Regarding current trading prices, 3446.T is priced at ¥1,944.00, while 7716.T trades at ¥2,799.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

3446.T currently has a P/E ratio of 125.91, whereas 7716.T's P/E ratio is -97.56. In terms of profitability, 3446.T's ROE is +0.03%, compared to 7716.T's ROE of -0.02%. Regarding short-term risk, 3446.T is more volatile compared to 7716.T. This indicates potentially higher risk in terms of short-term price fluctuations for 3446.T.Check 7716.T's competition here

3446.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 3446.T stands at 11.4B. In comparison, 3360.T has a market cap of 208.9B. Regarding current trading prices, 3446.T is priced at ¥1,944.00, while 3360.T trades at ¥2,270.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

3446.T currently has a P/E ratio of 125.91, whereas 3360.T's P/E ratio is 14.22. In terms of profitability, 3446.T's ROE is +0.03%, compared to 3360.T's ROE of +0.10%. Regarding short-term risk, 3446.T is more volatile compared to 3360.T. This indicates potentially higher risk in terms of short-term price fluctuations for 3446.T.Check 3360.T's competition here

3446.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 3446.T stands at 11.4B. In comparison, 7817.T has a market cap of 197.1B. Regarding current trading prices, 3446.T is priced at ¥1,944.00, while 7817.T trades at ¥3,515.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

3446.T currently has a P/E ratio of 125.91, whereas 7817.T's P/E ratio is 0.00. In terms of profitability, 3446.T's ROE is +0.03%, compared to 7817.T's ROE of +0.07%. Regarding short-term risk, 3446.T is more volatile compared to 7817.T. This indicates potentially higher risk in terms of short-term price fluctuations for 3446.T.Check 7817.T's competition here

3446.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 3446.T stands at 11.4B. In comparison, 7730.T has a market cap of 164.4B. Regarding current trading prices, 3446.T is priced at ¥1,944.00, while 7730.T trades at ¥1,669.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

3446.T currently has a P/E ratio of 125.91, whereas 7730.T's P/E ratio is 29.38. In terms of profitability, 3446.T's ROE is +0.03%, compared to 7730.T's ROE of +0.12%. Regarding short-term risk, 3446.T is less volatile compared to 7730.T. This indicates potentially lower risk in terms of short-term price fluctuations for 3446.T.Check 7730.T's competition here

3446.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 3446.T stands at 11.4B. In comparison, 3046.T has a market cap of 153.8B. Regarding current trading prices, 3446.T is priced at ¥1,944.00, while 3046.T trades at ¥6,590.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

3446.T currently has a P/E ratio of 125.91, whereas 3046.T's P/E ratio is 19.40. In terms of profitability, 3446.T's ROE is +0.03%, compared to 3046.T's ROE of +0.25%. Regarding short-term risk, 3446.T is less volatile compared to 3046.T. This indicates potentially lower risk in terms of short-term price fluctuations for 3446.T.Check 3046.T's competition here

3446.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 3446.T stands at 11.4B. In comparison, 3593.T has a market cap of 143.6B. Regarding current trading prices, 3446.T is priced at ¥1,944.00, while 3593.T trades at ¥6,660.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

3446.T currently has a P/E ratio of 125.91, whereas 3593.T's P/E ratio is 227.30. In terms of profitability, 3446.T's ROE is +0.03%, compared to 3593.T's ROE of +0.00%. Regarding short-term risk, 3446.T is more volatile compared to 3593.T. This indicates potentially higher risk in terms of short-term price fluctuations for 3446.T.Check 3593.T's competition here

3446.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 3446.T stands at 11.4B. In comparison, 7780.T has a market cap of 119.9B. Regarding current trading prices, 3446.T is priced at ¥1,944.00, while 7780.T trades at ¥1,617.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

3446.T currently has a P/E ratio of 125.91, whereas 7780.T's P/E ratio is 24.23. In terms of profitability, 3446.T's ROE is +0.03%, compared to 7780.T's ROE of +0.08%. Regarding short-term risk, 3446.T is more volatile compared to 7780.T. This indicates potentially higher risk in terms of short-term price fluctuations for 3446.T.Check 7780.T's competition here

3446.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 3446.T stands at 11.4B. In comparison, 7979.T has a market cap of 58.1B. Regarding current trading prices, 3446.T is priced at ¥1,944.00, while 7979.T trades at ¥1,632.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

3446.T currently has a P/E ratio of 125.91, whereas 7979.T's P/E ratio is 12.80. In terms of profitability, 3446.T's ROE is +0.03%, compared to 7979.T's ROE of +0.10%. Regarding short-term risk, 3446.T is more volatile compared to 7979.T. This indicates potentially higher risk in terms of short-term price fluctuations for 3446.T.Check 7979.T's competition here

3446.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 3446.T stands at 11.4B. In comparison, 5889.T has a market cap of 54B. Regarding current trading prices, 3446.T is priced at ¥1,944.00, while 5889.T trades at ¥2,230.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

3446.T currently has a P/E ratio of 125.91, whereas 5889.T's P/E ratio is 14.44. In terms of profitability, 3446.T's ROE is +0.03%, compared to 5889.T's ROE of +0.22%. Regarding short-term risk, 3446.T is more volatile compared to 5889.T. This indicates potentially higher risk in terms of short-term price fluctuations for 3446.T.Check 5889.T's competition here

3446.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 3446.T stands at 11.4B. In comparison, 368A.T has a market cap of 50.7B. Regarding current trading prices, 3446.T is priced at ¥1,944.00, while 368A.T trades at ¥1,268.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

3446.T currently has a P/E ratio of 125.91, whereas 368A.T's P/E ratio is 13.05. In terms of profitability, 3446.T's ROE is +0.03%, compared to 368A.T's ROE of N/A. Regarding short-term risk, 3446.T is more volatile compared to 368A.T. This indicates potentially higher risk in terms of short-term price fluctuations for 3446.T.Check 368A.T's competition here

3446.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 3446.T stands at 11.4B. In comparison, 7749.T has a market cap of 43.1B. Regarding current trading prices, 3446.T is priced at ¥1,944.00, while 7749.T trades at ¥2,975.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

3446.T currently has a P/E ratio of 125.91, whereas 7749.T's P/E ratio is 14.14. In terms of profitability, 3446.T's ROE is +0.03%, compared to 7749.T's ROE of +0.07%. Regarding short-term risk, 3446.T is more volatile compared to 7749.T. This indicates potentially higher risk in terms of short-term price fluctuations for 3446.T.Check 7749.T's competition here

3446.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 3446.T stands at 11.4B. In comparison, 3154.T has a market cap of 18.6B. Regarding current trading prices, 3446.T is priced at ¥1,944.00, while 3154.T trades at ¥837.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

3446.T currently has a P/E ratio of 125.91, whereas 3154.T's P/E ratio is 13.74. In terms of profitability, 3446.T's ROE is +0.03%, compared to 3154.T's ROE of +0.07%. Regarding short-term risk, 3446.T is more volatile compared to 3154.T. This indicates potentially higher risk in terms of short-term price fluctuations for 3446.T.Check 3154.T's competition here

3446.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 3446.T stands at 11.4B. In comparison, 7743.T has a market cap of 16.3B. Regarding current trading prices, 3446.T is priced at ¥1,944.00, while 7743.T trades at ¥540.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

3446.T currently has a P/E ratio of 125.91, whereas 7743.T's P/E ratio is 11.89. In terms of profitability, 3446.T's ROE is +0.03%, compared to 7743.T's ROE of +0.06%. Regarding short-term risk, 3446.T is more volatile compared to 7743.T. This indicates potentially higher risk in terms of short-term price fluctuations for 3446.T.Check 7743.T's competition here

3446.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 3446.T stands at 11.4B. In comparison, 7775.T has a market cap of 12.8B. Regarding current trading prices, 3446.T is priced at ¥1,944.00, while 7775.T trades at ¥446.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

3446.T currently has a P/E ratio of 125.91, whereas 7775.T's P/E ratio is 12.80. In terms of profitability, 3446.T's ROE is +0.03%, compared to 7775.T's ROE of +0.13%. Regarding short-term risk, 3446.T is more volatile compared to 7775.T. This indicates potentially higher risk in terms of short-term price fluctuations for 3446.T.Check 7775.T's competition here

3446.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 3446.T stands at 11.4B. In comparison, 7702.T has a market cap of 10.5B. Regarding current trading prices, 3446.T is priced at ¥1,944.00, while 7702.T trades at ¥427.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

3446.T currently has a P/E ratio of 125.91, whereas 7702.T's P/E ratio is 66.41. In terms of profitability, 3446.T's ROE is +0.03%, compared to 7702.T's ROE of -0.01%. Regarding short-term risk, 3446.T is more volatile compared to 7702.T. This indicates potentially higher risk in terms of short-term price fluctuations for 3446.T.Check 7702.T's competition here

3446.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 3446.T stands at 11.4B. In comparison, 4556.T has a market cap of 9.6B. Regarding current trading prices, 3446.T is priced at ¥1,944.00, while 4556.T trades at ¥2,273.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

3446.T currently has a P/E ratio of 125.91, whereas 4556.T's P/E ratio is 15.99. In terms of profitability, 3446.T's ROE is +0.03%, compared to 4556.T's ROE of +0.09%. Regarding short-term risk, 3446.T is more volatile compared to 4556.T. This indicates potentially higher risk in terms of short-term price fluctuations for 3446.T.Check 4556.T's competition here

3446.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 3446.T stands at 11.4B. In comparison, 3604.T has a market cap of 6.9B. Regarding current trading prices, 3446.T is priced at ¥1,944.00, while 3604.T trades at ¥1,198.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

3446.T currently has a P/E ratio of 125.91, whereas 3604.T's P/E ratio is 15.04. In terms of profitability, 3446.T's ROE is +0.03%, compared to 3604.T's ROE of +0.05%. Regarding short-term risk, 3446.T is more volatile compared to 3604.T. This indicates potentially higher risk in terms of short-term price fluctuations for 3446.T.Check 3604.T's competition here

3446.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 3446.T stands at 11.4B. In comparison, 9340.T has a market cap of 6.6B. Regarding current trading prices, 3446.T is priced at ¥1,944.00, while 9340.T trades at ¥676.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

3446.T currently has a P/E ratio of 125.91, whereas 9340.T's P/E ratio is 14.24. In terms of profitability, 3446.T's ROE is +0.03%, compared to 9340.T's ROE of +0.16%. Regarding short-term risk, 3446.T is more volatile compared to 9340.T. This indicates potentially higher risk in terms of short-term price fluctuations for 3446.T.Check 9340.T's competition here

3446.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 3446.T stands at 11.4B. In comparison, 7980.T has a market cap of 6.4B. Regarding current trading prices, 3446.T is priced at ¥1,944.00, while 7980.T trades at ¥895.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

3446.T currently has a P/E ratio of 125.91, whereas 7980.T's P/E ratio is 11.18. In terms of profitability, 3446.T's ROE is +0.03%, compared to 7980.T's ROE of +0.08%. Regarding short-term risk, 3446.T is less volatile compared to 7980.T. This indicates potentially lower risk in terms of short-term price fluctuations for 3446.T.Check 7980.T's competition here

3446.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 3446.T stands at 11.4B. In comparison, 7782.T has a market cap of 2.9B. Regarding current trading prices, 3446.T is priced at ¥1,944.00, while 7782.T trades at ¥443.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

3446.T currently has a P/E ratio of 125.91, whereas 7782.T's P/E ratio is 10.88. In terms of profitability, 3446.T's ROE is +0.03%, compared to 7782.T's ROE of +0.10%. Regarding short-term risk, 3446.T is more volatile compared to 7782.T. This indicates potentially higher risk in terms of short-term price fluctuations for 3446.T.Check 7782.T's competition here

3446.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 3446.T stands at 11.4B. In comparison, 7813.T has a market cap of 2.8B. Regarding current trading prices, 3446.T is priced at ¥1,944.00, while 7813.T trades at ¥838.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

3446.T currently has a P/E ratio of 125.91, whereas 7813.T's P/E ratio is 15.85. In terms of profitability, 3446.T's ROE is +0.03%, compared to 7813.T's ROE of +0.06%. Regarding short-term risk, 3446.T is more volatile compared to 7813.T. This indicates potentially higher risk in terms of short-term price fluctuations for 3446.T.Check 7813.T's competition here

3446.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 3446.T stands at 11.4B. In comparison, 7090.T has a market cap of 1.4B. Regarding current trading prices, 3446.T is priced at ¥1,944.00, while 7090.T trades at ¥933.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

3446.T currently has a P/E ratio of 125.91, whereas 7090.T's P/E ratio is -5.13. In terms of profitability, 3446.T's ROE is +0.03%, compared to 7090.T's ROE of -1.52%. Regarding short-term risk, 3446.T is more volatile compared to 7090.T. This indicates potentially higher risk in terms of short-term price fluctuations for 3446.T.Check 7090.T's competition here